Dr. Vijay Sharma's lab focuses on developing advanced PET imaging techniques to investigate the role of oxidative stress and inflammation in various diseases, particularly neurodegenerative disorders like Alzheimer's and chemotherapy-induced cardiotoxicity. The research aims to create novel imaging agents that can help visualize cellular processes related to mitochondrial function and response to treatments. By utilizing these new imaging tools, the lab hopes to enhance early diagnosis and improve the management of chronic diseases.

Dr. Yuan-Chuan Tai's lab focuses on developing advanced imaging technologies to enhance targeted radiopharmaceutical therapies for cancer treatment. Their innovative projects aim to create systems that allow for improved visualization and quantification of therapeutic agents within the body, thereby optimizing personalized medicine approaches. This research can lead to significant advancements in how therapies are administered and monitored, ultimately improving patient outcomes.

Dr. Song Hu's lab at Washington University focuses on developing advanced imaging techniques to study diseases like myofascial pain, Alzheimer's disease, and stroke. The lab creates innovative tools for tracking brain and muscle function over time, helping to identify the mechanisms behind these conditions, and developing new therapies. Ultimately, their research aims to improve diagnosis and treatment options for neurological and pain disorders.

Dr. Geoffrey D Hugo's lab at Washington University focuses on improving the safety and performance of artificial intelligence (AI) systems used in radiation oncology. The team is developing innovative quality assurance frameworks to monitor and ensure that AI systems function correctly in clinical settings. Their research addresses challenges posed by changing data distributions in medical imaging, aiming to enhance the clinical implementation of AI technologies.

Jessica Wagenseil's lab focuses on the study of ascending thoracic aortic aneurysms, which are dangerous cardiovascular conditions. The lab combines animal models, advanced computational techniques, and patient imaging data to identify potential biomarkers that can predict the failure of aneurysms. By examining a mouse model and utilizing complex simulations, the team aims to improve assessment and treatment strategies for patients at risk of aortic dissection or rupture.

Dr. Kevin M. Bennett's lab focuses on improving kidney transplantation outcomes by developing imaging techniques to better evaluate high-risk deceased donor kidneys. Many kidneys are discarded due to being labeled as low quality, but this project aims to validate and enhance the assessment of their health through advanced imaging methods. Ultimately, the goal is to reduce kidney waste and increase the availability of life-saving organs for patients in need.

Dr. Jianmin Cui's lab at Washington University focuses on understanding how specific mutations in the BK potassium channel affect brain activity and contribute to neurological disorders like epilepsy and movement disorders. By studying these mutations, the lab aims to develop targeted treatments that can better address the symptoms associated with these conditions. The research combines molecular biology, electrophysiology, and drug design to improve diagnosis and treatment options for patients with these genetic variants.

Dr. Aimilia Gastounioti's lab is focused on improving breast cancer risk assessment, particularly for Black women who are disproportionately affected by the disease. By utilizing digital breast tomosynthesis and advanced deep learning techniques, the lab aims to create robust risk prediction tools that can personalize screening and prevention strategies. This research strives to ensure that risk assessments are more accurate and applicable across diverse populations, ultimately contributing to better health outcomes and reduced mortality rates from breast cancer.

Dr. Hua Li's research focuses on improving the treatment of cervical cancer by utilizing advanced imaging techniques and RNA analyses. The goal is to develop personalized treatment strategies by predicting how well individual tumors will respond to therapy. The lab combines data from various sources, such as imaging and genetic information, to create robust models that can aid in clinical decision-making and improve patient outcomes.

Dr. Jin Zhang's lab at Washington University focuses on improving treatment outcomes for cervical cancer patients by developing predictive biomarkers and understanding the biology behind treatment resistance. Their research combines genomics and imaging techniques to identify patients at risk of treatment failure and to detect cancer recurrence early using advanced analytical methods. By integrating multi-omics data, the lab aims to personalize cancer therapy and enhance patient care.

Dr. Julie Kristina Schwarz's lab focuses on improving radiation therapy for cervical cancer by targeting the metabolism of glutamine, an amino acid crucial for cancer cell growth. The research aims to enhance anti-tumor immunity and increase the effectiveness of radiation treatment by combining it with a drug that inhibits glutamine metabolism. Through both laboratory studies and clinical trials, the lab works to develop innovative strategies for treating radiation-resistant cervical cancers.

Dr. Ganesh Chand's lab focuses on understanding Alzheimer's disease and its effects on brain function and behavior. Using advanced machine learning techniques, the lab studies the relationships between brain imaging markers, neuropsychiatric symptoms, and genetic factors in Alzheimer's patients and healthy controls. The goal is to uncover how different biological markers correlate with symptoms and identify distinct subgroups of patients, ultimately aiding in more personalized treatment approaches for the disease.

Dr. Joseph P. Culver's lab focuses on developing innovative optical imaging techniques to study brain development in children, particularly those with autism spectrum disorder (ASD). By creating a lightweight imaging system that allows for naturalistic brain mapping, his research aims to improve early detection of brain function alterations associated with ASD, which is crucial for timely intervention and better outcomes.

Dr. Adam Thomas Eggebrecht's lab focuses on improving the diagnosis and treatment of autism spectrum disorder (ASD) using advanced technology. The lab is working on a new method that combines wearable brain imaging with a computerized assessment to study motor imitation in children. This work aims to understand how motor imitation can help distinguish ASD from other developmental disorders, ultimately enhancing diagnostic accuracy and supporting better clinical care.

Dr. Manu Goyal's lab focuses on understanding the metabolic dysfunctions associated with Alzheimer's disease using advanced imaging techniques. By examining how amyloid plaques impact brain metabolism at both the cellular and network levels, the lab aims to unravel the connections between these metabolic changes and the progression of dementia. Ultimately, the research seeks to determine if treatments targeting amyloid can reverse these dysfunctions, paving the way for improved therapies for Alzheimer’s patients.

Dr. Tamara G. Hershey's lab focuses on understanding how type 2 diabetes (T2D) affects the brain, especially in youth who are at risk due to obesity and metabolic problems. The research aims to identify the connections between metabolic disorders and changes in brain structure and function, helping to better understand the complications associated with T2D in younger populations. This research is crucial as T2D is increasingly diagnosed in children and adolescents, and studying these effects early can lead to better intervention strategies.

Dr. Stephanie Markovina's lab focuses on improving treatment outcomes for cervical cancer, which remains a significant health challenge. By studying the role of a protein called SERPINB3, the lab aims to understand how certain tumor cells become resistant to radiation and chemotherapy and to develop new treatment strategies. Their research combines laboratory techniques with clinical trials to offer more effective, personalized treatment options for patients.

Dr. Aisling Chaney's lab focuses on advancing our understanding of the role of microglia in neurodegenerative diseases, like Alzheimer's and multiple sclerosis. The lab is developing a novel imaging technique using PET radiotracers specifically targeting THIK-1, a potassium channel found in microglia. This innovative approach aims to provide better insights into microglial activity and could lead to improved diagnosis and treatment options for neurological disorders.

Dr. Daniel Charles Castro's lab focuses on understanding how natural opioids in the brain influence motivation and behavior. They explore the role of specific regions in the midbrain that respond to these opioids, particularly looking at how they can both enhance and suppress motivated behaviors like eating and escaping threats. This research aims to provide insights into mental health conditions where motivation is affected, potentially identifying new treatment targets.

Dr. Jai Rudra's lab focuses on developing innovative vaccines using self-assembling nanofibers that can help combat neurodegenerative diseases such as Alzheimer's and frontotemporal dementia. The lab's approach uses specially designed peptides that form non-toxic nanofibers, encouraging the body to generate immune responses without the harmful side effects often seen with traditional vaccines. By studying how these nanofibers interact with the immune system, the lab aims to create safer and more effective therapies for these critical health challenges affecting aging populations.